In the BioHarmony Drug Report Database

"Preview" Icon

Mazindol

Mazanor, Sanorex (mazindol) is a small molecule pharmaceutical. Mazindol was first approved as Mazanor on 1982-01-01. It is used to treat duchenne muscular dystrophy and obesity in the USA. The pharmaceutical is active against sodium-dependent dopamine transporter. In addition, it is known to target sodium-dependent noradrenaline transporter.

 

Trade Name

 

Mazanor, Sanorex
 

Common Name

 

mazindol
 

ChEMBL ID

 

CHEMBL781
 

Indication

 

duchenne muscular dystrophy, obesity
 

Drug Class

 

Image (chem structure or protein)

Mazindol structure rendering